Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phorbol esters modulate the Ras exchange factor RasGRP3.

P S Lorenzo1, J W Kung, D A Bottorff

  • 1Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland 20892-4255, USA.

Cancer Research
|February 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Report on Criminal Abortion.

Iowa medical journal·2023
Same author

Treatment of Ununited Fractures.

The Chicago medical journal·2023
Same author

Causes and diagnostic utility of musculoskeletal MRI recall examinations.

Clinical radiology·2022
Same author

Putting the diabetes risk due to statins in perspective: a re-evaluation using the complementary outcome.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2014
Same author

Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action.

Biochemical pharmacology·2012
Same author

Primary intracranial leiomyosarcoma in an immunocompetent patient.

Clinical neuropathology·2011
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026
Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026
See all related articles

RasGRP3, a novel guanine nucleotide exchange factor, binds phorbol esters and activates Ras GTPases. This protein links tumor-promoting phorbol esters to Ras GTPase activation via a PKC-independent pathway.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • Ras guanine nucleotide exchange factors (GEFs) are crucial regulators of small GTPase signaling.
  • The RasGRP family represents a novel class of GEFs with unique structural motifs.
  • RasGRP3 (KIAA0846) is a recently identified member of the Ras guanine nucleotide-releasing protein (GRP) family.

Purpose of the Study:

  • To characterize the biochemical properties and cellular functions of RasGRP3.
  • To investigate the interaction of RasGRP3 with phorbol esters and diacylglycerol.
  • To elucidate the role of RasGRP3 in Ras GTPase activation.

Main Methods:

  • In vitro binding assays to assess phorbol ester and phospholipid interactions.
  • Cell-based assays measuring RasGTP levels and extracellular-regulated kinase (ERK) phosphorylation.

Related Experiment Videos

  • Confocal microscopy using green fluorescent protein (GFP)-tagged RasGRP3 to track subcellular localization.

    • Main Results:

    • RasGRP3 exhibits high-affinity binding to phorbol esters, dependent on anionic phospholipids.
    • Phorbol esters activate RasGRP3's GEF activity, leading to increased RasGTP and ERK phosphorylation in intact cells.
    • Diacylglycerol analogues and phorbol esters induce RasGRP3 redistribution to the plasma membrane and perinuclear regions.

    Conclusions:

    • RasGRP3 functions as a GEF that is regulated by phorbol esters and diacylglycerol.
    • RasGRP3 acts as a novel, protein kinase C (PKC)-independent pathway connecting phorbol esters to Ras GTPase activation.
    • These findings highlight RasGRP3's potential role in cellular processes influenced by tumor promoters.